期刊
BIOORGANIC CHEMISTRY
卷 131, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bioorg.2022.106331
关键词
Antibiotics; LpxC inhibitors; Aldotetronic acid derivatives; Molecular-docking studies; Bacterial uptake; LasB
To develop inhibitors for bacterial deacetylase LpxC, a series of aldotetronic acid-based hydroxamic acids were synthesized and tested for their inhibitory activity. The most potent inhibitor, benzyl ether 17a, was further evaluated for antibacterial activity, bacterial uptake, and susceptibility to efflux pumps. Molecular docking studies were performed to explain the observed structure-activity relationships.
In order to develop novel inhibitors of the bacterial deacetylase LpxC bearing a substituent to target the UDP binding site of the enzyme, a series of aldotetronic acid-based hydroxamic acids was accessed in chiral pool syntheses starting from 4,6-O-benzylidene-D-glucose and L-arabinitol. The synthesized hydroxamic acids were tested for LpxC inhibitory activity in vitro, revealing benzyl ether 17a ((2S,3S)-4-(benzyloxy)-N,3-dihydroxy-2[(4-{[4-(morpholinomethyl)phenyl]ethynyl}benzyl)oxy]butanamide) as the most potent LpxC inhibitor. This compound was additionally tested for antibacterial activity against a panel of clinically relevant Gram-negative bacteria, bacterial uptake, and susceptibility to efflux pumps. Molecular docking studies were performed to rationalize the observed structure-activity relationships.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据